Potential Therapy of HIV/AIDS and Ebola Outbreak with Pregnancy Hormone, Human Chorionic Gonadotropin

Crossmark: check for updates

Authors

  • C.V. Rao Departments of Cellular Biology and Pharmacology, Molecular and Human Genetics and Ob-stetrics and Gynecology, Herbert Wertheim College of Medicine, Florida International Univer-sity, Miami, Florida, 33199, USA

DOI:

https://doi.org/10.17140/HARTOJ-1-e002

Abstract

HIV is a retrovirus that destroys hosts’ immune system. AIDS is a late stage HIV infection. About 35 million people are living worldwide with HIV/AIDS, mostly in sub-Saharan Africa. Although there is no known cure, advances are constantly being made on how to better prevent and/or treat HIV/AIDS patients. Current anti-viral therapies are quite expensive, have side effects and do not work for everyone. Thus, there is a substantial unmet need for cost effective treatments, particularly in developing countries.

References

Lei ZM, Rao CV. The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol. 2007; 269: 2-8. doi: 10.1016/j.mce.2006.07.007

Syme M, Thornton G, Hann, M, Rao CV. Anti-HIV effects of human chorionic gonadotropin: potential for a new inexpensive therapy. In: Bandivedakar A, Puri CP (eds) Emerging Frontiers and Challenges in HIV/AIDS Research. Mumbai, India: Varun En-terprises; 2013: 119-123. HIV/AIDS Res Treat Open J Page e6

Downloads

Published

2014-11-10

How to Cite

C.V. Rao. (2014). Potential Therapy of HIV/AIDS and Ebola Outbreak with Pregnancy Hormone, Human Chorionic Gonadotropin. HIV/AIDS/Research/and/Treatment, 1(1), e5-e6. https://doi.org/10.17140/HARTOJ-1-e002

Issue

Vol. 1 No. 1 (2014): Volume 1 Issue 1 2014

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in HIV/AIDS Research and Treatment (HRT) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.